Antigen-pulsed engineered DCs induced significantly higher IFN-γ secretion and tumor cell killing than single-gene DCs, indicating the requirement of CD93, CD40L, and CXCL13 combination for optimal T cell activation and antitumor effects (Figure 5). This evidence concerns the gene CD93 and neoplasm.